Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Seretide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Seretide 125 Evohaler
0302000N0BCAEBF
|
Seretide | Fluticasone propionate (Inhalation) | Respiratory System | 94,475 |
|
Seretide 50 Evohaler
0302000N0BCADBE
|
Seretide | Fluticasone propionate (Inhalation) | Respiratory System | 90,482 |
|
Seretide 250 Evohaler
0302000N0BCAFBG
|
Seretide | Fluticasone propionate (Inhalation) | Respiratory System | 78,480 |
|
Seretide 500 Accuhaler
0302000N0BCACAZ
|
Seretide | Fluticasone propionate (Inhalation) | Respiratory System | 62,555 |
|
Seretide 250 Accuhaler
0302000N0BCABAY
|
Seretide | Fluticasone propionate (Inhalation) | Respiratory System | 56,946 |
|
Seretide 100 Accuhaler
0302000N0BCAAAX
|
Seretide | Fluticasone propionate (Inhalation) | Respiratory System | 38,424 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.